Pathstone Holdings’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$43.9K Sell
12,811
-8,052
-39% -$27.6K ﹤0.01% 2137
2025
Q1
$46.5K Sell
20,863
-500
-2% -$1.12K ﹤0.01% 2168
2024
Q4
$62.6K Sell
21,363
-10,140
-32% -$29.7K ﹤0.01% 2255
2024
Q3
$81.9K Buy
31,503
+14,693
+87% +$38.2K ﹤0.01% 2247
2024
Q2
$49.8K Sell
16,810
-228
-1% -$675 ﹤0.01% 2256
2024
Q1
$77.2K Buy
17,038
+324
+2% +$1.47K ﹤0.01% 2224
2023
Q4
$95.4K Buy
+16,714
New +$95.4K ﹤0.01% 2148